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Abstract: In view of the ongoing controversy of potential differences in cardiovascular safety of selective
COX-2 inhibitors (coxibs), we compared the effects of two different coxibs and a traditional NSAID on
endothelial dysfunction, a well established surrogate of cardiovascular disease, in salt-induced hyperten-
sion. Salt-sensitive (DS) and salt-resistant (DR) Dahl rats were treated with a high-sodium diet (4%
NaCl) for 56 days. From days 35 to 56, diclofenac (6 mg/kg/d; DS-diclofenac), rofecoxib (2 mg/kg/d;
DS-rofecoxib), celecoxib (25 mg/kg/d; DS-celecoxib) or placebo (DS-placebo) were added to the chow.
Vascular reactivity of isolated aortic rings was assessed by isometric tension recording. Blood pressure
increased with high sodium diet in the DS-groups which was more pronounced after diclofenac and ro-
fecoxib treatment (p<0.005 vs DS-placebo), but slightly blunted by celecoxib (p<0.001 vs DS-placebo).
Sodium diet markedly reduced NO-mediated endothelium-dependent relaxations to acetylcholine (ACh,
10−10−10−5 mol/L) in untreated hypertensive rats (p<0.0001 vs DR-placebo). Relaxation to ACh im-
proved after celecoxib (p<0.005 vs DS-placebo and DS-rofecoxib), but remained unchanged after rofecoxib
and diclofenac treatment. Vasoconstriction after NOS inhibition with N￿-Nitro-L-Arginine Methyl Ester
(10-4 mol/L) was blunted in DS rats (p<0.05 vs DR-placebo), normalized by celecoxib, but not affected
by rofecoxib or diclofenac. Protein expression of eNOS was decreased in DS rats with a trend for increased
eNOS levels in the DS-celecoxib group (97.8±25.6 vs 54.8±2.8 %, p=0.088 vs DS-placebo). Indicators
of oxidative stress, 8-isoprostane levels, were elevated in untreated DS rats on 4% NaCl (6.55±0.58 vs
3.65±1.05 ng/ml, p<0.05) and normalized by celecoxib only (4.29±0.58 ng/ml), while SOD protein ex-
pression was decreased in DS rats and not affected by any treatment. Plasma levels of prostaglandines
did not change during high sodium diet or any treatment. These data show that celecoxib, but not
rofecoxib or diclofenac, improves endothelial dysfunction and reduces oxidative stress, thus pointing to
differential effects of coxibs in salt-sensitive hypertension. Am J Hypertens (2004) 17, 243A-243A; doi:
10.1016/j.amjhyper.2004.03.650
DOI: https://doi.org/10.1016/j.amjhyper.2004.03.650
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Conclusions: These results suggest that superoxides generated by
angiotensin II-stimulated granulocyte mediate the adhesion of granulo-
cytes to endothelial cells.
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DIFFERENTIAL EFFECTS OF SELECTIVE
CYCLOOXYGENASE-2 INHIBITORS ON
ENDOTHELIAL FUNCTION IN SALT-INDUCED
HYPERTENSION
Matthias Hermann, Giovanni Camici, Felix C Tanner, Joachim Thiery,
Steffen Gay, Thomas F Luscher, Frank Ruschitzka. Cardiovascular
Center, Cardiology, University Hospital, Zurich, Switzerland; Institute
of Clinical Chemistry, Universitiy of Leipzig, Leipzig, Germany;
Center for Experimental Rheumatology, University Hospital, Zurich,
Switzerland.
Background: In view of the ongoing controversy of potential differences
in cardiovascular safety of selective COX-2 inhibitors (coxibs), we
compared the effects of two different coxibs and a traditional NSAID on
endothelial dysfunction, a well established surrogate of cardiovascular
disease, in salt-induced hypertension.
Methods and Results: Salt-sensitive (DS) and salt-resistant (DR)
Dahl rats were treated with a high-sodium diet (4% NaCl) for 56 days.
From days 35 to 56, diclofenac (6 mg/kg/d; DS-diclofenac), rofecoxib (2
mg/kg/d; DS-rofecoxib), celecoxib (25 mg/kg/d; DS-celecoxib) or pla-
cebo (DS-placebo) were added to the chow. Vascular reactivity of
isolated aortic rings was assessed by isometric tension recording. Blood
pressure increased with high sodium diet in the DS-groups which was
more pronounced after diclofenac and rofecoxib treatment (p0.005 vs
DS-placebo), but slightly blunted by celecoxib (p0.001 vs DS-pla-
cebo). Sodium diet markedly reduced NO-mediated endothelium-depen-
dent relaxations to acetylcholine (ACh, 1010105 mol/L) in untreated
hypertensive rats (p0.0001 vs DR-placebo). Relaxation to ACh im-
proved after celecoxib (p0.005 vs DS-placebo and DS-rofecoxib), but
remained unchanged after rofecoxib and diclofenac treatment. Vasocon-
striction after NOS inhibition with N-Nitro-L-Arginine Methyl Ester
(10-4 mol/L) was blunted in DS rats (p0.05 vs DR-placebo), normalized
by celecoxib, but not affected by rofecoxib or diclofenac. Protein expres-
sion of eNOS was decreased in DS rats with a trend for increased eNOS
levels in the DS-celecoxib group (97.825.6 vs 54.82.8 %, p0.088 vs
DS-placebo). Indicators of oxidative stress, 8-isoprostane levels, were
elevated in untreated DS rats on 4% NaCl (6.550.58 vs 3.651.05
ng/ml, p0.05) and normalized by celecoxib only (4.290.58 ng/ml),
while SOD protein expression was decreased in DS rats and not affected
by any treatment. Plasma levels of prostaglandines did not change during
high sodium diet or any treatment.
Conclusion: These data show that celecoxib, but not rofecoxib or
diclofenac, improves endothelial dysfunction and reduces oxidative
stress, thus pointing to differential effects of coxibs in salt-sensitive
hypertension.
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GENDER-RELATED DIFFERENCE IN THE
ASSOCIATION BETWEEN C-REACTIVE PROTEIN
AND AMBULATORY BLOOD PRESSURE IN
JAPANESE HYPERTENSIVE PATIENTS
Joji Ishikawa, Kario Kazuomi, Masato Morinari, Satoshi Hoshide,
Kazuo Eguchi, Shizukiyo Ishikawa, Kazuyuki Shimada. Cardiology,
Jichi Medical School, Yakushiji 3311-1, Minamikawachimachi,
Tochigi, Japan; Community and Family Medicine, Jichi Medical
School, Yakushiji 3311-1, Minamikawachimachi, Tochigi, Japan.
Purpose: C-reactive protein (CRP), a marker of inflammation, is asso-
ciated with cardiovascular events and may be related to the pathogenesis
of hypertension. We evaluated the relationship between CRP and ambu-
latory blood pressure (BP) in Japanese.
Method: We studied 514 Japanese hypertensives (clinic BP140/
90mmHg; 191 men and 323 women) aged50 years (mean age: 72
years) in Jichi Medical School and related facilities.
Results: CRP showed a skewed deviation and a median CRP level was
0.20 mg/dl (75 percentile: 0.40mg/dl, 90 percentile: 0.74mg/dl). In the
total subjects, CRP level was positively correlated with age (r0.177,
P0.001) and clinic heart rate (r0.093, P0.034). In men, CRP level
was positively correlated with clinic heart rate (r0.251, P0.003),
24-hr systolic BP (24-hr SBP, r0.157, P0.030) bur not with 24-hr
diastolic BP (24-hr DBP, r0.087, P0.231). In women, CRP level was
correlated with neither 24-hr SBP (r0.007, p0.901) nor 24-hr DBP
(r0.027, p0.625). Sustained hypertensives men (24-hr
SBP135mmHg) had higher CRP level than white-coat hypertensives
(24-hr SBP135mmHg) (0.455 vs. 0.286 mg/dl, P0.039). In multiple
regression analyses, 24-hr SBP in men was positively correlated with
CRP (r0.165, P0.024) independently of confounding factors.
Conclusion: Gender-related difference was found in the association
between CRP and ambulatory BP in hypertensive Japanese. Low-grade
inflammation is involved in increased ambulatory BP in Japanese hyper-
tensive men, but not in women.
Key Words: C-Reactive Protein, Ambulatory Blood Pressure Monitor-
ing, Gender Difference
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INTERLEUKIN 15 IS ASSOCIATED WITH
CARDIOVASCULAR COMPLICATIONS IN PATIENTS
WITH ESSENTIAL HYPERTENSION
Masaharu Kaibe, Mitsuru Ohishi, Norihisa Ito, Ming Yuan, Takeshi
Takagi, Minako Terai, Hiromi Rakugi, Toshio Ogihara. Department of
Geriatric Medicine, Osaka University Graduate School of Medicine,
Suita City, Osaka, Japan.
A statement of the purpose of the study: IL-15 is a cytokine produced
from inflammatory cells, of which expression is immunohistochemically
found in inflammatory cells adjacent to vulnerable atherosclerotic
plaques. Systemic inflammatory substances are related to cardiovascular
events, however, influence of systemic IL-15 levels on cardiovascular
diseases is still unclear. Therefore, we designed clinical investigations to
clarify the relationship between serum IL-15 levels and hypertensive
complications.
A statement of the methods used: Three hundreds and ninety-nine
patients with essential hypertension (222 males and 177 females, mean
age: 610.7 y.o.) were enrolled. We excluded patients with inflamma-
tory or infectious diseases, or patients who were administered steroids
and aspirins. We divided objectives into the following 3 groups accord-
ing to modified WHO classification in 1993; patients with no complica-
tion (NC, n236), with mild organ damages (MOD, n112), with severe
organ damages (SOD, n51). MOD was determined as left ventricular
hypertrophy by electrocardiogram and echocardiography, narrowing of
retinal artery, proteinuria (20mg/dl), renal dysfunction (1.2mg/
dLserum creatinine2.0mg/dL), and/or carotid plaque. SOD was de-
termined as coronary artery diseases (CAD), congestive heart failure,
stroke, and/or peripheral artery disease (PAD). Serum IL-15 levels were
measured by ELISA kit (BioSource International, Inc).
A summary of the results presented in sufficient detail to support
the conclusions: Serum IL-15 levels in patients with SOD
(96.120.7pg/ml) were significantly higher than that with MOD
(46.57.6pg/ml; p0.01) and that with NC (56.36.8pg/ml; p0.05).
Serum IL-15 levels in patients with CAD (n17) were significantly
higher than that without CAD (p0.0001). Serum IL-15 levels with PAD
(n29) were significantly higher than that of patients without PAD
(p0.05). Moreover, serum IL-15 levels in patients with lacuna infarc-
tion (n73) were significantly higher than that without lacuna infarction
(p0.005).
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